The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?

dc.contributor.author	Pehlivanoglu, Seren
dc.contributor.author	Acar, Nur
dc.contributor.author	Albayrak, Sinan
dc.contributor.author	Karakaya, Muharrem
dc.contributor.author	Ofluoglu, Ali
dc.date.accessioned	2021-12-21T08:45:48Z
dc.date.available	2021-12-21T08:45:48Z
dc.date.issued	2018
dc.identifier.issn	1177-5483
dc.identifier.uri	https://doi.org/10.2147/OPTH.S164960
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1772
dc.description.abstract	Background: Our purpose was to demonstrate if measuring lens autofluorescence (AF) with a scanning confocal biomicroscope may be used to identify subjects with undiagnosed type II diabetes mellitus (DM), and hence, for it to be used as a marker for the se
dc.language.iso	English
dc.publisher	Dove Medıcal Press Ltd
dc.rights	gold, Green Published, Green Submitted
dc.title	The assessment of autofluorescence of the crystalline lens in diabetic patients and healthy controls: can it be used as a screening test?
dc.type	Article
dc.relation.journal	Clınıcal Ophthalmology
dc.identifier.startpage	1163
dc.identifier.endpage	1170
dc.identifier.volume	12
dc.identifier.doi	10.2147/OPTH.S164960
dc.relation.volume	12